Form 4 Tracker
Anthony Mancini

Chief Global Commercialization Officer · 8 filings · Latest: Sep 24, 2026

Revolution Medicines, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
RVMD
Anthony ManciniChief Global Commercialization OfficerSep 25, 2026
Sale
$200.543,121$625.9K39,765
RVMD
Anthony ManciniChief Global Commercialization OfficerSep 25, 2026
Option Exercise
$33.623,121$104.9K42,886
RVMD
Anthony ManciniChief Global Commercialization OfficerSep 24, 2026
Sale
$200.00587$117.4K39,765
RVMD
ANTHONY MANCINI—Sep 25, 2026
Proposed Sale
$199.869,363$1.9M—
RVMD
ANTHONY MANCINI—Sep 24, 2026
Proposed Sale
$190.74587$112.0K—
RVMD
Anthony ManciniChief Global Commercialization OfficerSep 18, 2026
Sale
$196.941,764$347.4K40,352
RVMD
Anthony ManciniChief Global Commercialization OfficerSep 16, 2026
Sale
$199.241,774$353.4K42,116
RVMD
ANTHONY MANCINI—Sep 18, 2026
Proposed Sale
$196.941,764$347.4K—
RVMD
Mancini Anthony—Sep 15, 2026
Proposed Sale
$203.772,377$484.4K—
RVMD
Anthony ManciniChief Global Commercialization OfficerSep 10, 2026
Sale
$204.1615,448$3.2M43,890
RVMD
Anthony ManciniChief Global Commercialization OfficerSep 10, 2026
Option Exercise
$33.629,363$314.8K59,338
RVMD
ANTHONY MANCINI—Sep 10, 2026
Proposed Sale
$207.6815,448$3.2M—
RVMD
Anthony ManciniChief Global Commercialization OfficerJun 16, 2026
Sale
$156.124,615$720.5K49,975
RVMD
Mancini Anthony—Jun 15, 2026
Proposed Sale
$153.874,211$647.9K—
RVMD
Anthony ManciniChief Global Commercialization OfficerMay 26, 2026
Sale
$153.993,121$480.6K54,400
RVMD
Anthony ManciniChief Global Commercialization OfficerMay 26, 2026
Option Exercise
$33.623,121$104.9K57,521
RVMD
ANTHONY MANCINI—May 26, 2026
Proposed Sale
$151.563,121$473.0K—
RVMD
Anthony ManciniChief Global Commercialization OfficerApr 27, 2026
Sale
$132.413,120$413.1K54,400
RVMD
Anthony ManciniChief Global Commercialization OfficerApr 27, 2026
Option Exercise
$33.623,120$104.9K57,520
RVMD
ANTHONY MANCINI—Apr 27, 2026
Proposed Sale
$135.303,120$422.1K—

Page 1 of 2

Next →